Adipogenic transdifferentiation reprograms EMT-high PDAC cells into a post-mitotic adipocyte-like state and limits metastasis

Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10–45.

Google Scholar 

Dreyer SB, Beer P, Hingorani SR, Biankin AV. Improving outcomes of patients with pancreatic cancer. Nat Rev Clin Oncol. 2025;22:439–56.

Google Scholar 

Park W, Chawla A, O’Reilly EM. Pancreatic cancer: a review. JAMA. 2021;326:851–62.

Google Scholar 

Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, Maitra A. Pancreatic cancer: advances and challenges. Cell. 2023;186:1729–54.

Google Scholar 

J Jeiroshi A, Deng J, Xu Z, Comandatore A, Xu G, Glaviano A, et al. Navigating the paradox of senescence and chemoresistance in pancreatic cancer. Semin Cancer Biol. 2025;114:60–72.

Google Scholar 

Hu ZI, O’Reilly EM. Therapeutic developments in pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2024;21:7–24.

Google Scholar 

Ho WJ, Jaffee EM, Zheng L. The tumour microenvironment in pancreatic cancer – clinical challenges and opportunities. Nat Rev Clin Oncol. 2020;17:527–40.

Google Scholar 

Houbracken I, de Waele E, Lardon J, Ling Z, Heimberg H, Rooman I, et al. Lineage tracing evidence for transdifferentiation of acinar to duct cells and plasticity of human pancreas. Gastroenterology. 2011;141:731–41.

Google Scholar 

Schneider AT, Koppe C, Crouchet E, Papargyriou A, Singer MT, Büttner V, et al. A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic cancer development. Nat Commun. 2025;16:1765.

Google Scholar 

Petrov MS. Fatty change of the pancreas: the Pandora’s box of pancreatology. Lancet Gastroenterol Hepatol. 2023;8:671–82.

Google Scholar 

Matsumoto S, Mori H, Miyake H, Takaki H, Maeda T, Yamada Y, et al. Uneven fatty replacement of the pancreas: evaluation with CT. Radiology. 1995;194:453–8.

Google Scholar 

Targher G, Rossi AP, Zamboni GA, Fantin F, Antonioli A, Corzato F, et al. Pancreatic fat accumulation and its relationship with liver fat content and other fat depots in obese individuals. J Endocrinol Investig. 2012;35:748–53.

Google Scholar 

Genovese G, Carugo A, Tepper J, Robinson FS, Li L, Svelto M, et al. Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. Nature. 2017;542:362–6.

Google Scholar 

David CJ, Huang Y-H, Chen M, Su J, Zou Y. TGF-β tumor suppression through a lethal EMT. Cell. 2016;35:320–30.

Google Scholar 

Perelli L, Zhang L, Mangiameli S, Giannese F, Mahadevan KK, Peng F, et al. Evolutionary fingerprints of epithelial-to-mesenchymal transition. Nature. 2025;640:1083–92.

Google Scholar 

Zheng X, Carstens JL, Kim J, Scheible M, Kaye J, Sugimoto H, et al. EMT program is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature. 2015;20:525–30.

Google Scholar 

Collisson EA, Sadanandam A, Olson P, Gibb WJ, Truitt M, Gu S, et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat Med. 2011;17:500–3.

Google Scholar 

Maddipati R, Norgard RJ, Baslan T, Rathi KS, Zhang A, Saeid A, et al. MYC levels regulate metastatic heterogeneity in pancreatic adenocarcinoma. Cancer Discov. 2022;12:542–61.

Google Scholar 

Feldmann K, Maurer C, Peschke K, Teller S, Schuck K, Steiger K, et al. Mesenchymal plasticity regulated by Prrx1 drives aggressive pancreatic cancer biology. Gastroenterology. 2021;160:346–.e24.

Google Scholar 

Benitz S, Steep A, Nasser MM, Preall J, Mahajan UM, McQuithey H, et al. ROR2 regulates cellular plasticity in pancreatic neoplasia and adenocarcinoma. Cancer Discov. 2024;14:2162–82.

Google Scholar 

Baba T, Finetti P, Lillemoe KD, Warshaw AL, Fernández-Del Castillo C, Liss AS. A lesson in transcriptional plasticity: classical identity is silenced, but not lost, in pancreatic ductal adenocarcinoma cell lines. Gastroenterology. 2022;163:1450–.e3.

Google Scholar 

Raghavan S, Winter PS, Navia AW, Williams HL, DenAdel A, Lowder KE, et al. Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer. Cell. 2021;184:6119–6137.e26.

Google Scholar 

Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 1988;72:567–72.

Google Scholar 

Ishay-Ronen D, Diepenbruck M, Kalathur RKR, Sugiyama N, Tiede S, Ivanek R, et al. Gain fat—lose metastasis: converting invasive breast cancer cells into adipocytes inhibits cancer metastasis. Cancer Cell. 2019;35:17–32.

Google Scholar 

Kopinke D, Roberson EC, Reiter JF. Ciliary hedgehog signaling restricts injury-induced adipogenesis. Cell. 2017;170:340–351.e12.

Google Scholar 

Wang QA, Scherer PE, Gupta RK. Improved methodologies for the study of adipose biology: insights gained and opportunities ahead. J Lipid Res. 2014;55:605–24.

Google Scholar 

Lan L, Evan T, Li H, Hussain A, Ruiz EJ, Zaw Thin M, et al. GREM1 is required to maintain cellular heterogeneity in pancreatic cancer. Nature. 2022;607:163–8.

Google Scholar 

Huang Y, Hong W, Wei X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J Hematol Oncol. 2022;15:129.

Google Scholar 

Wu Z, Rosen ED, Brun R, Hauser S, Adelmant G, Troy AE, et al. Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell. 1999;3:151–8.

Google Scholar 

Rosen ED, Hsu CH, Wang X, Sakai S, Freeman MW, Gonzalez FJ, et al. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev. 2002;16:22–26.

Google Scholar 

Chen Y, Liang R, Li Y, Jiang L, Ma D, Luo Q, et al. Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application. Signal Transduct Target Ther. 2024;9:340.

Google Scholar 

Perkins ML, Crocker J, Tkačik G. Chromatin enables precise and scalable gene regulation with factors of limited specificity. Proc Natl Acad Sci USA. 2025;122:e2411887121.

Google Scholar 

Varghese AM, Perry MA, Chou JF, Nandakumar S, Muldoon D, Erakky A, et al. Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival. Nat Med. 2025;31:466–77.

Google Scholar 

Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, et al. Guidelines and definitions for research on epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2020;21:341–52.

Google Scholar 

Seton-Rogers S. Epithelial-mesenchymal transition: untangling EMT’s functions. Nat Rev Cancer. 2016;16:1.

Google Scholar 

Cui J, Zhang C, Lee JE, Bartholdy BA, Yang D, Liu Y, et al. MLL3 loss drives metastasis by promoting a hybrid epithelial-mesenchymal transition state. Nat Cell Biol. 2023;25:145–58.

Google Scholar 

Kawai M, Fukuda A, Ikeda M, Iimori K, Mizukoshi K, Iwane K, et al. Polybromo 1/vimentin axis dictates tumor grade, epithelial-mesenchymal transition, and metastasis in pancreatic cancer. J Clin Investig. 2025;135:e177533.

Russell R, Perkhofer L, Liebau S, Lin Q, Lechel A, Feld FM, et al. Loss of ATM accelerates pancreatic cancer formation and epithelial-mesenchymal transition. Nat Commun. 2015;6:7677.

Google Scholar 

Wirth M, Schneider G. A hypoxia-epigenetics axis drives EMT in pancreatic cancer. Cancer Res. 2024;84:1739–41.

Google Scholar 

Brown BA, Myers PJ, Adair SJ, Pitarresi JR, Sah-Teli SK, Campbell LA, et al. A histone methylation-MAPK Signaling axis drives durable epithelial-mesenchymal transition in hypoxic pancreatic cancer. Cancer Res. 2024;84:1764–80.

Google Scholar 

Wang Y, Bu F, Royer C, Serres S, Larkin JR, Soto MS, et al. ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1. Nat Cell Biol. 2014;16:1092–104.

Google Scholar 

Huang S, Qin X, Fu S, Hu J, Jiang Z, Hu M, et al. STAMBPL1/TRIM21 balances AXL stability impacting mesenchymal phenotype and immune response in KIRC. Adv Sci. 2025;12:e2405083.

Google Scholar 

Petrov MS, Taylor R. Intra-pancreatic fat deposition: bringing hidden fat to the fore. Nat Rev Gastroenterol Hepatol. 2022;19:153–68.

Google Scholar 

Chen WH, Horoszewicz JS, Leong SS, Shimano T, Penetrante R, Sanders WH, et al. Human pancreatic adenocarcinoma: in vitro and in vivo morphology of a new tumor line established from ascites. In Vitro. 1982;18:24–34.

Google Scholar 

Yu Q, Dong Y, Wang X, Su C, Zhang R, Xu W, et al. Pharmacological induction of MHC-I expression in tumor cells revitalizes T cell antitumor immunity. JCI insight. 2024;9:e177788.

Zhong L, Gan L, Wang B, Wu T, Yao F, Gong W, et al. Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients. Cell. 2025;188:1119–1136.e23.

Google Scholar 

Lito P, Saborowski A, Yue J, Solomon M, Joseph E, Gadal S, et al. Disruption of CRAF-mediated MEK activation is required for effective MEK inhibition in KRAS mutant tumors. Cancer Cell. 2014;25:697–710.

Google Scholar 

Infante JR, Somer BG, Park JO, Li CP, Scheulen ME, Kasubhai SM, et al. A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas. Eur J Cancer. 2014;50:2072–81.

Google Scholar 

Zhang S, Deng S, Liu J, Liu S, Chen Z, Liu S, et al. Targeting MXD1 sensitises pancreatic cancer to trametinib. Gut. 2025;74:1262–78.

Google Scholar 

Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47:W556–W560.

Google Scholar 

Sakaguchi M, Fujisaka S, Cai W, Winnay JN, Konishi M, O’Neill BT, et al. Adipocyte dynamics and reversible metabolic syndrome in mice with an inducible adipocyte-specific deletion of the insulin receptor. Cell Metab. 2017;25:448–62.

Google Scholar 

Jiang H, Lei R, Ding S-W, Zhu S. Skewer: a fast and accurate adapter trimmer for next-generation sequencing paired-end reads. BMC Bioinformatics. 2014;15:182.

Google Scholar 

Wingett SW, Andrews S. FastQ screen: a tool for multi-genome mapping and quality control. F1000Research. 2018;7:1338.

Google Scholar 

Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15–21.

Google Scholar 

Pertea M, Pertea GM, Antonescu CM, Chang T-C, Mendell JT, Salzberg SL. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol. 2015;33:290–5.

Google Scholar 

Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.

Google Scholar 

Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27–30.

Google Scholar 

Alexa A, Rahnenführer J, Lengauer T. Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics. 2006;22:1600–7.

Google Scholar 

Bentsen M, Goymann P, Schultheis H, Klee K, Petrova A, Wiegandt R, et al. ATAC-seq footprinting unravels kinetics of transcription factor binding during zygotic genome activation. Nat Commun. 2020;11:4267.

Google Scholar